+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tamoxifen"

From
From
Triple Negative Breast Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Triple Negative Breast Cancer - Epidemiology Forecast - 2032

  • Report
  • September 2023
  • 112 Pages
  • Global
From
From
From
FASLODEX Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FASLODEX Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Research Report on China's Anastrozole Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Anastrozole Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Tamoxifen is a drug used to treat breast cancer. It is a selective estrogen receptor modulator (SERM) that works by blocking the effects of estrogen in the body. Tamoxifen is used to treat both early and advanced stages of breast cancer, and is often used in combination with other drugs. It is also used to reduce the risk of breast cancer in women at high risk of developing the disease. Tamoxifen is available in both oral and injectable forms, and is typically taken for five to ten years. Tamoxifen is one of the most widely used drugs for the treatment of breast cancer, and is often prescribed in combination with other drugs. It is also used to reduce the risk of recurrence in women who have already been treated for breast cancer. The Tamoxifen market is highly competitive, with many companies offering generic versions of the drug. Companies such as Pfizer, AstraZeneca, Novartis, and Teva Pharmaceuticals are some of the major players in the market. Other companies such as Mylan, Sun Pharmaceuticals, and Dr. Reddy's Laboratories also offer generic versions of Tamoxifen. Show Less Read more